About the TrialUpdates

Are you living with chronic kidney disease?

If you are at least 18 years of age and referred for arteriovenous fistula creation surgery, you may be eligible for the SAVE-FistulaS clinical trial

Learn About the Trial

Standard of Care

Arteriovenous fistulas are the standard of care in hemodialysis. Unfortunately, they have a 50 - 60% 1-year failure rate, resulting in catheter reliance, interventions, and many other complications that adversely impact patients.

Our Goal

At VenoStent, we are working to improve the usability and durability of AVFs for more reliable dialysis. This could have a positive impact on patient care and quality of life for chronic kidney disease (CKD) patients.


If you are eligible for this trial and elect to participate, you will be compensated for your participation. Ask your doctor for more details.

Latest Updates
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
Jan 30, 2024
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
See all updates
clinicaltrials.gov: NCT06001827

SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational device. Limited by federal law to investigational use.

© 2024 VenoStent, Inc. All rights reserved.